日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A case of immune thrombocytopenia aggravated by therapy for hypercortisolism in adrenocortical carcinoma

一例因肾上腺皮质癌高皮质醇血症治疗而加重的免疫性血小板减少症病例报告

Kaneda, Ryo; Murakami, Masanori; Hirano, Akiko; Nakayama, Airi; Uchida, Satoru; Tsujimoto, Kazutaka; Komiya, Chikara; Ikeda, Kenji; Fujiwara, Hiroki; Nagao, Toshikage; Yoshida, Soichiro; Fujii, Yasuhisa; Yamada, Tetsuya

Induction chemotherapy with methotrexate, nimustine, and procarbazine for primary CNS lymphoma in the elderly: a retrospective evaluation of safety and efficacy

老年原发性中枢神经系统淋巴瘤诱导化疗方案(甲氨蝶呤、尼莫司汀和丙卡巴肼):安全性和有效性的回顾性评价

Umezawa, Yoshihiro; Yamamoto, Masahide; Tanaka, Keisuke; Yoshifuji, Kota; Akiyama, Hiroki; Nogami, Ayako; Nagao, Toshikage; Mori, Takehiko

Classical Hodgkin lymphoma associated with immune deficiency and dysregulation exhibits a prognosis similar to sporadic cases but with distinct predictive markers

与免疫缺陷和失调相关的经典型霍奇金淋巴瘤的预后与散发性病例相似,但具有不同的预测标志物。

Mukae, Junichi; Akiyama, Hiroki; Tanaka, Keisuke; Yoshifuji, Kota; Nogami, Ayako; Umezawa, Natsuka; Umezawa, Yoshihiro; Yamamoto, Kouhei; Nagao, Toshikage; Yasuda, Shinsuke; Kanegane, Hirokazu; Takagi, Masatoshi; Mori, Takehiko; Yamamoto, Masahide

Tumor progression locus 2, a new potential prognostic factor and therapeutic target in activated B-cell-like diffuse large B-cell lymphoma

肿瘤进展位点2:活化B细胞样弥漫性大B细胞淋巴瘤的一个新的潜在预后因素和治疗靶点

Yoshifuji, Kota; Motomura, Yotaro; Saito, Makiko; Kawade, Genji; Watabe, Shiori; Yamamoto, Kouhei; Soejima, Mai; Nogami, Ayako; Aoyama, Satoru; Mori, Takehiko; Nagao, Toshikage

Impact of genetic alterations on central nervous system progression of primary vitreoretinal lymphoma

基因改变对原发性玻璃体视网膜淋巴瘤中枢神经系统进展的影响

Yoshifuji, Kota; Sadato, Daichi; Toya, Takashi; Motomura, Yotaro; Hirama, Chizuko; Takase, Hiroshi; Yamamoto, Kouhei; Harada, Yuka; Mori, Takehiko; Nagao, Toshikage

An early regulatory mechanism of hyperinflammation by restricting monocyte contribution

通过限制单核细胞贡献来调节炎症过度的早期机制

Megumi Akiyama #, Masashi Kanayama #, Yoshihiro Umezawa, Toshikage Nagao, Yuta Izumi, Masahide Yamamoto, Toshiaki Ohteki

18q Deletion Syndrome Presenting with Late-Onset Combined Immunodeficiency

18q缺失综合征伴迟发性联合免疫缺陷

Hashiguchi, Sho; Tomomasa, Dan; Nishikawa, Takuro; Ishikawa, Shuji; Akaike, Harumi; Kobae, Hidehiko; Shirai, Tsuyoshi; Nagao, Toshikage; Noma, Kosuke; Okada, Satoshi; Kamuro, Kazuhiro; Okamoto, Yasuhiro; Kanegane, Hirokazu

Hepatitis C virus-related hepatitis flare after immunochemotherapy in a patient with follicular lymphoma

滤泡性淋巴瘤患者接受免疫化疗后出现丙型肝炎病毒相关性肝炎复发

Motomura, Yotaro; Yoshifuji, Kota; Tanaka, Keisuke; Sakashita, Chizuko; Umezawa, Yoshihiro; Nagao, Toshikage; Nitta, Sayuri; Asahina, Yasuhiro; Mori, Takehiko; Yamamoto, Masahide

Targeting USP14/UCHL5: A Breakthrough Approach to Overcoming Treatment-Resistant FLT3-ITD-Positive AML

靶向 USP14/UCHL5:克服治疗耐药性 FLT3-ITD 阳性 AML 的突破性方法

Ayako Nogami, Hideki Jose Amemiya, Hiroki Fujiwara, Yoshihiro Umezawa, Shuji Tohda, Toshikage Nagao

Lymphoproliferative disorder risk after methotrexate treatment for rheumatoid arthritis

甲氨蝶呤治疗类风湿性关节炎后淋巴增生性疾病的风险

Tanaka, Keisuke; Ichikawa, Ayako; Umezawa, Natsuka; Yamamoto, Kouhei; Yoshifuji, Kota; Okada, Keigo; Nogami, Ayako; Umezawa, Yoshihiro; Nagao, Toshikage; Sakashita, Chizuko; Mori, Takehiko; Tohda, Shuji; Koike, Ryuji; Yasuda, Shinsuke; Yamamoto, Masahide